| Full Name | Alina Rim |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 4532 Chelton Ct Se, Smyrna, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710490743 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN2297827 (Massachusetts) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 117442 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Atlanta Anesthesia Professionals, Llc | 5496134348 | 432 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
| Entity Name | Physician Specialists In Anesthesia, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316968662 PECOS PAC ID: 9830170059 Enrollment ID: O20040525000912 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
| Entity Name | Gastroenterology Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942563242 PECOS PAC ID: 3779730080 Enrollment ID: O20120821000929 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
| Entity Name | Coastal Ambulatory Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750753786 PECOS PAC ID: 1052613023 Enrollment ID: O20160107001775 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
| Entity Name | Gi Anesthesia Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326569187 PECOS PAC ID: 0446516769 Enrollment ID: O20171102000283 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
| Entity Name | Anesthesia Dynamics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20200508002106 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
| Entity Name | North Atlanta Anesthesia Professionals, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982349296 PECOS PAC ID: 5496134348 Enrollment ID: O20220623000371 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alina Rim, 4532 Chelton Ct Se, Smyrna, GA 30080-6901 Ph: (770) 380-1935 | Alina Rim, 4532 Chelton Ct Se, Smyrna, GA 30080 Ph: (770) 380-1935 |
News Archive
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.
CLEW Medical, formerly known as Intensix, is launching its AI predictive-analytics platform to prevent life threatening complications in all care settings, using real-time data and machine learning technology. Already proven in the ICU, CLEW's platform provides medical staff and healthcare administrators with actionable clinical, operational and financial insights to streamline medical care.
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
› Verified 3 days ago
Dr. Diane Powe-cronin, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4619 Gann Xing Sw, Smyrna, GA 30082 Phone: 229-269-2751 | |
Mrs. Dana F. Mccormick, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4210 Hill House Rd Sw, Smyrna, GA 30082 Phone: 404-216-1075 |